Suchergebnisse

Discure Technologies Accepted into FDA TAP Program for Its Breakthrough Device for Degenerative Disc Disease Discure Technologies, developing a bioelectronic implant for degenerative disc disease, a leading cause of back pain, is accepted into FDA's TAP Program.